Canada approves Pfizer-BioNTech Covid-19 vaccine for age 12 and older
The approval is based on data from the Phase 3 clinical trial, which enrolled 2,260 adolescents aged 12…
Roche gets EC approval for Tecentriq to treat people with metastatic NSCLC
06 May 21The EC approval represents Tecentriq’s fourth indication in metastatic NSCLC and fifth indication in lung cancer overall in…
Pfizer reports 45% increase in Q1 2021 net income to $4.8bn
05 May 21Pfizer said that its first-quarter 2021 operational growth was primarily driven by the Pfizer-BioNTech Covid-19 vaccine, BNT162b2, which…
Athenex to acquire Kuur Therapeutics for $185m
05 May 21Kuur’s NKT cell platform technology will help Athenex to expand its cell therapy development capabilities
Swiss firm Roivant Sciences to go public in $7.3bn deal
04 May 21The transaction will enable Roivant Sciences to become a public entity and is expected to be listed on…
Aceragen acquires Enzyvant’s investigational therapy to treat Farber disease
04 May 21The investigational therapy has been designed to address the genetic deficiency of the naturally occurring enzyme which is…
AstraZeneca gets FDA approval for Farxiga to treat chronic kidney disease
03 May 21Farxiga is said to have reduced the risk of the composite of worsening of renal function, end-stage kidney…
Bristol Myers gets FDA priority review for Opdivo to treat bladder cancer
03 May 21The company filed its sBLA application based on the Phase 3 CheckMate -274 trial, in which Opdivo increased…
Lumenis gets FDA nod for OptiLight to manage dry eye disease
30 Apr 21OptiLight is an IPL device indicated for patients aged 22 years and above with symptoms of DED due…
Xeris’ Ogluo injection approved in UK to treat severe hypoglycaemia
30 Apr 21Ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged two years and…